aluates Reports

$ 0.0

Automative

Global Remicade (infliximab) Drug Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-21E12265

Global Remicade infliximab Drug Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Remicade (infliximab) Drug Market Research Report 2025

Code: QYRE-Auto-21E12265

Report

August 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Celltrion Healthcare

Epirus Biopharmaceuticals

Samsung Bioepsis

J & J

Pfizer Inc

J & J

Remicade (infliximab) Drug Market Size

The global market for Remicade (infliximab) Drug was valued at US$ 2920 million in the year 2024 and is projected to reach a revised size of US$ 4253 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Remicade (infliximab) Drug Market

Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Remicade (infliximab) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remicade (infliximab) Drug.

The Remicade (infliximab) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Remicade (infliximab) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Remicade (infliximab) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Remicade (infliximab) Drug Market Report

Report Metric	Details
Report Name	Remicade (infliximab) Drug Market
Accounted market size in year	US$ 2920 million
Forecasted market size in 2031	US$ 4253 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Brands Drugs Generic Drugs
Segment by Application	Crohn's Disease Pediatric Crohn's Disease Ulcerative Colitis Pediatric Ulcerative Colitis Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	J & J, Pfizer, Celltrion Healthcare, Epirus Biopharmaceuticals, Samsung Bioepsis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remicade (infliximab) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Remicade (infliximab) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Remicade (infliximab) Drug Market growing?

Ans: The Remicade (infliximab) Drug Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Remicade (infliximab) Drug Market size in 2031?

Ans: The Remicade (infliximab) Drug Market size in 2031 will be US$ 4253 million.

Who are the main players in the Remicade (infliximab) Drug Market report?

Ans: The main players in the Remicade (infliximab) Drug Market are J & J, Pfizer, Celltrion Healthcare, Epirus Biopharmaceuticals, Samsung Bioepsis

What are the Application segmentation covered in the Remicade (infliximab) Drug Market report?

Ans: The Applications covered in the Remicade (infliximab) Drug Market report are Crohn's Disease, Pediatric Crohn's Disease, Ulcerative Colitis, Pediatric Ulcerative Colitis, Other

What are the Type segmentation covered in the Remicade (infliximab) Drug Market report?

Ans: The Types covered in the Remicade (infliximab) Drug Market report are Brands Drugs, Generic Drugs

Recommended Reports

Autoimmune Drugs

Biologics & Biosimilars

Infectious Disease Drugs

1 Remicade (infliximab) Drug Market Overview

1.1 Product Definition

1.2 Remicade (infliximab) Drug by Type

1.2.1 Global Remicade (infliximab) Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Brands Drugs

1.2.3 Generic Drugs

1.3 Remicade (infliximab) Drug by Application

1.3.1 Global Remicade (infliximab) Drug Market Value by Application (2024 VS 2031)

1.3.2 Crohn's Disease

1.3.3 Pediatric Crohn's Disease

1.3.4 Ulcerative Colitis

1.3.5 Pediatric Ulcerative Colitis

1.3.6 Other

1.4 Global Remicade (infliximab) Drug Market Size Estimates and Forecasts

1.4.1 Global Remicade (infliximab) Drug Revenue 2020-2031

1.4.2 Global Remicade (infliximab) Drug Sales 2020-2031

1.4.3 Global Remicade (infliximab) Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Remicade (infliximab) Drug Market Competition by Manufacturers

2.1 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Remicade (infliximab) Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Remicade (infliximab) Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Remicade (infliximab) Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Remicade (infliximab) Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Remicade (infliximab) Drug, Product Type & Application

2.7 Global Key Manufacturers of Remicade (infliximab) Drug, Date of Enter into This Industry

2.8 Global Remicade (infliximab) Drug Market Competitive Situation and Trends

2.8.1 Global Remicade (infliximab) Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Remicade (infliximab) Drug Players Market Share by Revenue

2.8.3 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Remicade (infliximab) Drug Market Scenario by Region

3.1 Global Remicade (infliximab) Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Remicade (infliximab) Drug Sales by Region: 2020-2031

3.2.1 Global Remicade (infliximab) Drug Sales by Region: 2020-2025

3.2.2 Global Remicade (infliximab) Drug Sales by Region: 2026-2031

3.3 Global Remicade (infliximab) Drug Revenue by Region: 2020-2031

3.3.1 Global Remicade (infliximab) Drug Revenue by Region: 2020-2025

3.3.2 Global Remicade (infliximab) Drug Revenue by Region: 2026-2031

3.4 North America Remicade (infliximab) Drug Market Facts & Figures by Country

3.4.1 North America Remicade (infliximab) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Remicade (infliximab) Drug Sales by Country (2020-2031)

3.4.3 North America Remicade (infliximab) Drug Revenue by Country (2020-2031)

3.4.4 the United States

3.4.5 Canada

3.5 Europe Remicade (infliximab) Drug Market Facts & Figures by Country

3.5.1 Europe Remicade (infliximab) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Remicade (infliximab) Drug Sales by Country (2020-2031)

3.5.3 Europe Remicade (infliximab) Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Remicade (infliximab) Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Remicade (infliximab) Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Remicade (infliximab) Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Remicade (infliximab) Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Remicade (infliximab) Drug Market Facts & Figures by Country

3.7.1 Latin America Remicade (infliximab) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Remicade (infliximab) Drug Sales by Country (2020-2031)

3.7.3 Latin America Remicade (infliximab) Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Remicade (infliximab) Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Remicade (infliximab) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Remicade (infliximab) Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Remicade (infliximab) Drug Sales by Type (2020-2031)

4.1.1 Global Remicade (infliximab) Drug Sales by Type (2020-2025)

4.1.2 Global Remicade (infliximab) Drug Sales by Type (2026-2031)

4.1.3 Global Remicade (infliximab) Drug Sales Market Share by Type (2020-2031)

4.2 Global Remicade (infliximab) Drug Revenue by Type (2020-2031)

4.2.1 Global Remicade (infliximab) Drug Revenue by Type (2020-2025)

4.2.2 Global Remicade (infliximab) Drug Revenue by Type (2026-2031)

4.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Type (2020-2031)

4.3 Global Remicade (infliximab) Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Remicade (infliximab) Drug Sales by Application (2020-2031)

5.1.1 Global Remicade (infliximab) Drug Sales by Application (2020-2025)

5.1.2 Global Remicade (infliximab) Drug Sales by Application (2026-2031)

5.1.3 Global Remicade (infliximab) Drug Sales Market Share by Application (2020-2031)

5.2 Global Remicade (infliximab) Drug Revenue by Application (2020-2031)

5.2.1 Global Remicade (infliximab) Drug Revenue by Application (2020-2025)

5.2.2 Global Remicade (infliximab) Drug Revenue by Application (2026-2031)

5.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Application (2020-2031)

5.3 Global Remicade (infliximab) Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 J & J

6.1.1 J & J Company Information

6.1.2 J & J Description and Business Overview

6.1.3 J & J Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 J & J Remicade (infliximab) Drug Product Portfolio

6.1.5 J & J Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Remicade (infliximab) Drug Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Celltrion Healthcare

6.3.1 Celltrion Healthcare Company Information

6.3.2 Celltrion Healthcare Description and Business Overview

6.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Celltrion Healthcare Remicade (infliximab) Drug Product Portfolio

6.3.5 Celltrion Healthcare Recent Developments/Updates

6.4 Epirus Biopharmaceuticals

6.4.1 Epirus Biopharmaceuticals Company Information

6.4.2 Epirus Biopharmaceuticals Description and Business Overview

6.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Portfolio

6.4.5 Epirus Biopharmaceuticals Recent Developments/Updates

6.5 Samsung Bioepsis

6.5.1 Samsung Bioepsis Company Information

6.5.2 Samsung Bioepsis Description and Business Overview

6.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Samsung Bioepsis Remicade (infliximab) Drug Product Portfolio

6.5.5 Samsung Bioepsis Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Remicade (infliximab) Drug Industry Chain Analysis

7.2 Remicade (infliximab) Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Remicade (infliximab) Drug Production Mode & Process Analysis

7.4 Remicade (infliximab) Drug Sales and Marketing

7.4.1 Remicade (infliximab) Drug Sales Channels

7.4.2 Remicade (infliximab) Drug Distributors

7.5 Remicade (infliximab) Drug Customer Analysis

8 Remicade (infliximab) Drug Market Dynamics

8.1 Remicade (infliximab) Drug Industry Trends

8.2 Remicade (infliximab) Drug Market Drivers

8.3 Remicade (infliximab) Drug Market Challenges

8.4 Remicade (infliximab) Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Celltrion Healthcare

Epirus Biopharmaceuticals

Samsung Bioepsis

J & J

Pfizer Inc

J & J

List of Tables

Table 1. Global Remicade (infliximab) Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Remicade (infliximab) Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Remicade (infliximab) Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Remicade (infliximab) Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Remicade (infliximab) Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Remicade (infliximab) Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Remicade (infliximab) Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Remicade (infliximab) Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Remicade (infliximab) Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Remicade (infliximab) Drug, Product Type & Application

Table 12. Global Key Manufacturers of Remicade (infliximab) Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Remicade (infliximab) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remicade (infliximab) Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Remicade (infliximab) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Remicade (infliximab) Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Remicade (infliximab) Drug Sales Market Share by Region (2020-2025)

Table 19. Global Remicade (infliximab) Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Remicade (infliximab) Drug Sales Market Share by Region (2026-2031)

Table 21. Global Remicade (infliximab) Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Remicade (infliximab) Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Remicade (infliximab) Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Remicade (infliximab) Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Remicade (infliximab) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Remicade (infliximab) Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Remicade (infliximab) Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Remicade (infliximab) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Remicade (infliximab) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Remicade (infliximab) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Remicade (infliximab) Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Remicade (infliximab) Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Remicade (infliximab) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Remicade (infliximab) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Remicade (infliximab) Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Remicade (infliximab) Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Remicade (infliximab) Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Remicade (infliximab) Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Remicade (infliximab) Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Remicade (infliximab) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Remicade (infliximab) Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Remicade (infliximab) Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Remicade (infliximab) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Remicade (infliximab) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Remicade (infliximab) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Remicade (infliximab) Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Remicade (infliximab) Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Remicade (infliximab) Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Remicade (infliximab) Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Remicade (infliximab) Drug Sales Market Share by Type (2020-2025)

Table 53. Global Remicade (infliximab) Drug Sales Market Share by Type (2026-2031)

Table 54. Global Remicade (infliximab) Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Remicade (infliximab) Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Remicade (infliximab) Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Remicade (infliximab) Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Remicade (infliximab) Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Remicade (infliximab) Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Remicade (infliximab) Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Remicade (infliximab) Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Remicade (infliximab) Drug Sales Market Share by Application (2020-2025)

Table 63. Global Remicade (infliximab) Drug Sales Market Share by Application (2026-2031)

Table 64. Global Remicade (infliximab) Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Remicade (infliximab) Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Remicade (infliximab) Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Remicade (infliximab) Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Remicade (infliximab) Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Remicade (infliximab) Drug Price (USD/Unit) by Application (2026-2031)

Table 70. J & J Company Information

Table 71. J & J Description and Business Overview

Table 72. J & J Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. J & J Remicade (infliximab) Drug Product

Table 74. J & J Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Remicade (infliximab) Drug Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Celltrion Healthcare Company Information

Table 81. Celltrion Healthcare Description and Business Overview

Table 82. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Celltrion Healthcare Remicade (infliximab) Drug Product

Table 84. Celltrion Healthcare Recent Developments/Updates

Table 85. Epirus Biopharmaceuticals Company Information

Table 86. Epirus Biopharmaceuticals Description and Business Overview

Table 87. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product

Table 89. Epirus Biopharmaceuticals Recent Developments/Updates

Table 90. Samsung Bioepsis Company Information

Table 91. Samsung Bioepsis Description and Business Overview

Table 92. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Samsung Bioepsis Remicade (infliximab) Drug Product

Table 94. Samsung Bioepsis Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Remicade (infliximab) Drug Distributors List

Table 98. Remicade (infliximab) Drug Customers List

Table 99. Remicade (infliximab) Drug Market Trends

Table 100. Remicade (infliximab) Drug Market Drivers

Table 101. Remicade (infliximab) Drug Market Challenges

Table 102. Remicade (infliximab) Drug Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Remicade (infliximab) Drug

Figure 2. Global Remicade (infliximab) Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Remicade (infliximab) Drug Market Share by Type: 2024 & 2031

Figure 4. Brands Drugs Product Picture

Figure 5. Generic Drugs Product Picture

Figure 6. Global Remicade (infliximab) Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Remicade (infliximab) Drug Market Share by Application: 2024 & 2031

Figure 8. Crohn's Disease

Figure 9. Pediatric Crohn's Disease

Figure 10. Ulcerative Colitis

Figure 11. Pediatric Ulcerative Colitis

Figure 12. Other

Figure 13. Global Remicade (infliximab) Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Remicade (infliximab) Drug Market Size (2020-2031) & (US$ Million)

Figure 15. Global Remicade (infliximab) Drug Sales (2020-2031) & (K Units)

Figure 16. Global Remicade (infliximab) Drug Average Price (USD/Unit) & (2020-2031)

Figure 17. Remicade (infliximab) Drug Report Years Considered

Figure 18. Remicade (infliximab) Drug Sales Share by Manufacturers in 2024

Figure 19. Global Remicade (infliximab) Drug Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Remicade (infliximab) Drug Players: Market Share by Revenue in Remicade (infliximab) Drug in 2024

Figure 21. Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Remicade (infliximab) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Remicade (infliximab) Drug Sales Market Share by Country (2020-2031)

Figure 24. North America Remicade (infliximab) Drug Revenue Market Share by Country (2020-2031)

Figure 25. the United States Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Remicade (infliximab) Drug Sales Market Share by Country (2020-2031)

Figure 28. Europe Remicade (infliximab) Drug Revenue Market Share by Country (2020-2031)

Figure 29. Germany Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. UK Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Remicade (infliximab) Drug Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Remicade (infliximab) Drug Revenue Market Share by Region (2020-2031)

Figure 36. China Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Remicade (infliximab) Drug Sales Market Share by Country (2020-2031)

Figure 46. Latin America Remicade (infliximab) Drug Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Remicade (infliximab) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Remicade (infliximab) Drug by Type (2020-2031)

Figure 56. Global Revenue Market Share of Remicade (infliximab) Drug by Type (2020-2031)

Figure 57. Global Remicade (infliximab) Drug Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Remicade (infliximab) Drug by Application (2020-2031)

Figure 59. Global Revenue Market Share of Remicade (infliximab) Drug by Application (2020-2031)

Figure 60. Global Remicade (infliximab) Drug Price (USD/Unit) by Application (2020-2031)

Figure 61. Remicade (infliximab) Drug Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Remicade Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infliximab Injection Market Research Report 2024

Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030

Biosimilar of Remicade Market

Global TNF Inhibitors for the Treatment of Rheumatoid Arthritis Market Research Report 2024

Etanercept Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Necrosis Factor Alpha Inhibitors Market Research Report 2024

Global Ustekinumab Biosimilars Market Research Report 2024

Adalimumab Humira and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adalimumab Market Insights Forecast to 2030

Global Etanercept Solution for Injection Market Research Report 2024

Global Rituximab Biosimilars Market Research Report 2025

Enbrel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Enbrel Etanercept and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Necrosis Factor TNF Inhibitor Drugs Market Insights Forecast to 2030

Global Recombinant Human Tumor Necrosis Factor α ReceptorⅡ IgG Fc Fusion Protein for Injection Market Research Report 2024

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16G6108

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27Q5892

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14K19926

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15N17310

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions